JOURNAL OF GERONTOLOGY AND GERIATRICS
https://www.jgerontology-geriatrics.com/
<div class="section "><label for="description-localization-popover-container-5dc00ec6337c8">Journal summary</label> - inglese</div> <div class="section "> <div> <h2>Cos’è Lorem Ipsum?</h2> <p><strong>Lorem Ipsum</strong> è un testo segnaposto utilizzato nel settore della tipografia e della stampa. Lorem Ipsum è considerato il testo segnaposto standard sin dal sedicesimo secolo, quando un anonimo tipografo prese una cassetta di caratteri e li assemblò per preparare un testo campione. È sopravvissuto non solo a più di cinque secoli, ma anche al passaggio alla videoimpaginazione, pervenendoci sostanzialmente inalterato. Fu reso popolare, negli anni ’60, con la diffusione dei fogli di caratteri trasferibili “Letraset”, che contenevano passaggi del Lorem Ipsum, e più recentemente da software di impaginazione come Aldus PageMaker, che includeva versioni del Lorem Ipsum.</p> </div> </div>Pacini Editore Srlen-USJOURNAL OF GERONTOLOGY AND GERIATRICS2499-6564<p style="margin-bottom: 0cm; line-height: 100%; orphans: 0; widows: 0;" align="justify"><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><strong>AUTHORSHIP STATEMENT FORM</strong></span></span></span></p> <p style="margin-bottom: 0cm; line-height: 100%; orphans: 0; widows: 0;" align="justify"><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><strong>The corresponding author must sign the </strong></span></span></span><a href="/libraryFiles/downloadPublic/3"><span style="color: #d71f2b;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><strong>Authorship Statement Form</strong></span></span></span></a><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><strong>, save it in .pdf and return it by uploading at our submission platform </strong></span></span></span><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><strong>http://www.jgerontology-geriatrics.com</strong></span></span></p> <p style="margin-bottom: 0cm; line-height: 100%; orphans: 0; widows: 0;" align="justify"> </p> <p style="margin-bottom: 0cm; line-height: 100%; orphans: 0; widows: 0;" align="justify"><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><strong>It is the policy of the Journal to correspond exclusively with one designated corresponding author. As the corresponding author, it is your responsibility to communicate with your co-authors.</strong></span></span></span></p> <p style="margin-bottom: 0cm; line-height: 100%; orphans: 0; widows: 0;" align="justify"> </p> <p style="margin-bottom: 0cm; line-height: 100%; orphans: 0; widows: 0;" align="justify"><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><strong>AUTHORSHIP RESPONSIBILITY</strong></span></span></span></p> <p style="margin-bottom: 0cm; line-height: 100%; orphans: 0; widows: 0;" align="justify"><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">(1) All authors participated sufficiently in the intellectual content, analysis of data (if applicable) and writing of the article, by the criteria for authorship by the International Committee of Medical Journal Editors (http://www.icmje.org/). (2) The corresponding author certifies that the definitive version of the manuscript has been approved by all co-authors, as well as, director of the Institute or Department where the work has been carried out. (3) All persons who have made substantial contributions to the work reported in this manuscript (e.g., data collection, writing or editing assistance) but who do not fulfill the authorship criteria are named along with their specific contributions as an acknowledgement in the manuscript. The corresponding author certifies that all persons named in the acknowledgement section have provided written permission to be named. (4) All authors have reviewed the final version of the article and approve it for publication. (5) Authors must state that the article submitted has previously published, and is not under consideration or accepted for publication (in whole or in part) elsewhere nor have assigned any right or interest in the article to any third party. (6) Written permission from the authors to reproduce any material copyright elsewhere has been obtained prior to submission. (7) Authors must specify that consent has been obtained from taking part in the investigations or, in the case of paediatric patients, from the guardian/s and that they have obtained written releases from patients whose names or photographs are submitted as part of the article. (8) For reports containing original corresponding author should have full access to all the data in the study and takes responsibility for the integrity of the data accuracy of data analysis. (9) Any manuscript concerned with human subjects, medical records, or human tissue that is submitted “Journal of Gerontology and Geriatrics” should comply with the principles stated in the Declaration of Helsinki “Ethical Principles Medical Research Involving ‘Human Subjects”, adopted by the 18 World Medical Assembly, Helsinki, Finland, June 1964, amended most recently by the 64 World Medical Assembly, Fontaleza, Brazil, October 2013. If the study involves human subjects or records of human patients ethical approval MUST have been obtained. The corresponding author must state ethical approval was given, by whom and the relevant Judgement</span></span></span><span style="color: #212529;"><span style="font-family: American Typewriter, serif;"><span style="font-size: medium;">ʼ</span></span></span><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">s reference number. The manuscript should contain a statement that the work has been approved by the appropriate Ethical Committee related to the institution(s) in which the work was and that subjects gave informed consent to the work. “Journal of Gerontology and Geriatrics” requires institutional Ethics Committee approval for all human studies. For retrospective studies on patients</span></span></span><span style="color: #212529;"><span style="font-family: American Typewriter, serif;"><span style="font-size: medium;">ʼ</span></span></span><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"> records either a statement of approval or a statement exemption from the Committee is required. </span></span></span><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><strong>Ref N° of the Ethical Committee Approval must be indicated in the <a href="/libraryFiles/downloadPublic/3">Authorship Statement Form</a>. The study was approved by the Institutional Ethical Committee (the Name of the Institution must indicated in the <a href="/libraryFiles/downloadPublic/3">Authorship Statement Form</a>) and this is clearly stated in the Methods section of the article.</strong></span></span></span><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"> This statement should also be provided upon submission of the manuscript. Studies involving experiments with animals must state that their was in accordance with institution guidelines and relevant national laws. (10) The article contains no libelous or unlawful statements,</span></span></span></p> <p style="margin-bottom: 0cm; line-height: 100%; orphans: 0; widows: 0;" align="justify"><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">does not infringe the privacy of others, or contains material or instructions that might cause harm or injury. The corresponding author shall indemnify and hold the Editors and its agents and licensees harmless from any damages, costs, and expenses reasonable attorney</span></span></span><span style="color: #212529;"><span style="font-family: American Typewriter, serif;"><span style="font-size: medium;">ʼ</span></span></span><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">s fees and costs of settlement) resulting by reason of any claim, action, or proceeding finally sustained settled inconsistent with the foregoing warranties and representations. (11) All manuscripts are screened for plagiarism, which</span></span></span></p> <p style="margin-bottom: 0cm; line-height: 100%; orphans: 0; widows: 0;" align="justify"><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">implies immediate rejection. Suspected plagiarism is handled in accordance with the COPE flowcharts (http://publicationethics.org/resources/flowcharts).</span></span></span></p> <p style="margin-bottom: 0cm; line-height: 100%; orphans: 0; widows: 0;" align="justify"><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">Every author or co-author of any article published in this Journal is solely responsible for the contents of the article, for the statement made in their paper and for the material sent. Every author or co-author needs to fully comply with the Regulation 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard processing of personal data and on the free movement of such data, and repealing Directive 95/46/EC (General Data Protection Regulation): “</span></span></span><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><em>Article 9. Processing of personal data revealing racial or ethnic origin, political opinions, religious or philosophical beliefs, or trade union membership, and the processing of genetic data, biometric data for the purpose of uniquely identifying natural person, data concerning health or data concerning a natural person's sex life or sexual orientation shall be prohibited</em></span></span></span><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">”.</span></span></span></p> <p style="margin-bottom: 0cm; line-height: 100%; orphans: 0; widows: 0;" align="justify"> </p> <p style="margin-bottom: 0cm; line-height: 100%; orphans: 0; widows: 0;" align="justify"><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><strong>PRIVACY POLICY STATEMENT. </strong></span></span></span><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">Personal data of the author will be managed by the Publisher in full compliance with the legislation on the privacy protection (art. 13 of EU regulation 2016/6799). According to articles 15-20 of the GDPR, any author may exercise specific rights, including the right to obtain access to personal data in an intelligible form, correct, update or them. Authors will also have the right to obtain from the Publisher limitation of data processing, and may also oppose to data processing legitimate reasons. In the case that the author believes that processing of his/her own personal data infringes GDPR regulation, he/she has the right to make a complaint to the Supervisory Authority for the Protection of Personal Data to art. 77 of the GDPR. Controller of data processing, according to art. 4.1.7 of the GDPR, is Mrs. Donatella Paoletti for Pacini Srl, with registered office in 56121 Pisa, Italy, Via A Gherardesca n. 1. To exercise the rights of GDPR referred to in paragraph same article, you can address any request for information to the following e-mail: privacy@pacinieditore.it. For further information refer to the website: http://www.jgerontology-geriatrics.com/informativa-privacy-privacy-policy/</span></span></span></p> <p style="margin-bottom: 0cm; line-height: 100%; orphans: 0; widows: 0;" align="justify"> </p> <p style="margin-bottom: 0cm; line-height: 100%; orphans: 0; widows: 0;" align="justify"><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><strong>FINANCIAL DISCLOSURE. </strong></span></span></span><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">All authors must state any information that may be perceived as potential conflict of interest. must disclose all their affiliations including any relevant personal or institutional financial involvement (employment by an concern, consultancies, honoraria, speakers bureau, stock ownership or options, expert testimony, grants received or pending, membership on a standing advisory council or committee, a seat on the board of directors, or being publicly associated with company or its products, royalties, donation of medical equipment, etc.) with any organization that to any author</span></span></span><span style="color: #212529;"><span style="font-family: American Typewriter, serif;"><span style="font-size: medium;">ʼ</span></span></span><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">s knowledge direct interest, particularly a financial interest, in the subject matter or materials discussed. This declaration will be treated Editor as confidential while the paper is under review, and will not be made known to Reviewers. Please indicate on the </span></span></span><strong><a href="/libraryFiles/downloadPublic/3"><span style="color: #d71f2b;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">Authorship</span></span></span> <span style="color: #d71f2b;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">Statement Form </span></span></span></a></strong><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">whether or not you have or may have such a conflict of interest regarding the content of this article and nature of it.</span></span></span></p> <p style="margin-bottom: 0cm; line-height: 100%; orphans: 0; widows: 0;" align="justify"> </p> <p style="margin-bottom: 0cm; line-height: 100%; orphans: 0; widows: 0;" align="justify"><a name="_GoBack"></a> <span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><strong>COPYRIGHT TRANSFER AGREEMENT</strong></span></span></span><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">. (a) Authors assign to “Journal of Gerontology and Geriatrics”, all copyright in and to including but not limited to the right to publish, republish, transmit, sell, distribute and otherwise use the article in whole or electronic and print editions of the Journal and in derivative works throughout the world, in all languages and in all media expression now known or later developed, and to license or permit others to do so. (b) The authors retain all proprietary rights, than copyright, such as patent rights. The authors retain the right to reuse any portion of the work, without charge, in personal compilations or other publications consisting solely of the author(s</span></span></span><span style="color: #212529;"><span style="font-family: American Typewriter, serif;"><span style="font-size: medium;">ʼ</span></span></span><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">) own works, including the author(s</span></span></span><span style="color: #212529;"><span style="font-family: American Typewriter, serif;"><span style="font-size: medium;">ʼ</span></span></span><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">) personal web home and to make copies of all or part of the Work for the author(s</span></span></span><span style="color: #212529;"><span style="font-family: American Typewriter, serif;"><span style="font-size: medium;">ʼ</span></span></span><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">) use for lecture or classroom purposes. The corresponding declares that any person named as co-author of the article is aware of the submission and has agreed to being so named. corresponding author accepts responsibility for releasing this material on behalf of any and all co-authors. The corresponding declares that statements and opinions given in the article are the expression of the authors. Responsibility for the content article rests upon the authors.</span></span></span></p>Progression of cognitive decline in older adult patients with dementia: the role of atrial fibrillation and oral anticoagulant therapy
https://www.jgerontology-geriatrics.com/article/view/796
<p><strong>Background/aim</strong>. The pathophysiology of dementia remains incompletely understood, and there are conflicting findings regarding the contribution of atrial fibrillation (AF) to cognitive decline. Additionally,<br>oral anticoagulants may influence the progression of dementia. This study aims to explore whether AF is associated with the progression of cognitive decline and functional deterioration in older adults with dementia. Additionally, it seeks to evaluate the potential impact of anticoagulant therapy on cognitive and functional decline.<br><strong>Methods</strong>. This observational retrospective study involved 179 older adults with dementia under the care of the University of Padua from 2015 to 2020. Each participant underwent a two-year observation period, during which cognitive function was assessed using the Mini-Mental State Examination (MMSE), and functional abilities were measured with the Activities of Daily Living (ADL) and Instrumental Activities of Daily Living (IADL) scales.<br>Results. AF patients made up 29.6% of the sample. According to ANOVA test for repeated measures, no significant differences in MMSE scores were observed over time between the AF and nAF groups or across the three time points based on anticoagulant therapy type. However, individuals with nAF showed a more pronounced decline in IADL and ADL scores over time. Linear mixed model analysis revealed that Alzheimer’s dementia (-1.98, 95% CI: -3.16, -0.79; p = 0.001) and age (-0.09, 95% CI: -0.18, -0.00; p = 0.044) were significantly associated with MMSE decline. Significant predictors of IADL decline included male sex (-1.20, 95% CI: -1.77, -0.64, p < 0.001), MMSE (0.15, 95% CI: 0.06, 0.25, p = 0.002), and age (-0.08, 95% CI: -0.13, -0.04, p < 0.001), with a notable interaction between nAF and time (-0.48, 95% CI: -0.86, -0.12, p = 0.010). For ADL, MMSE (0.15, 95% CI: 0.09, 0.22, p < 0.001), and age (-0.03, 95% CI: -0.07, -0.003, p < 0.001) were the main predictors.<br><strong>Conclusions</strong>. AF was not identified as a factor associated with cognitive decline when accounting for other variables. Instead, age and the presence of Alzheimer’s disease emerged as key factors linked to functional and cognitive deterioration.</p>Giulia TassoEleonora MizzonChiara CeolinMarina De RuiMaria DevitaAnna BertoccoBruno Micael ZanforliniChiara CurreriGiuseppe SergiAlessandra Coin
Copyright (c) 2025 JOURNAL OF GERONTOLOGY AND GERIATRICS
2025-06-252025-06-2573334010.36150/2499-6564-N796Differential physical activity patterns in cognitively impaired vs healthy older adults using accelerometers
https://www.jgerontology-geriatrics.com/article/view/872
<p><strong>Objective</strong>. Physical Activity (PA) plays a pivotal role as a protective factor against the development of dementia and is associated with cognitive performance. However, quantitative data collected on older adults under ecological conditions remain limited. In the present study, a continuous longitudinal assessment of PA parameters was performed to clarify if differences in daily and hourly patterns of PA exist in older adults who differ by cognitive status.<br><strong>Methods</strong>. Seventy-two adults aged 65+ were categorized by cognitive status (cognitively impaired [CI] vs healthy controls [HC]) and monitored using wrist-worn accelerometers to assess daily and hourly PA levels, including the percentage of time spent in PA at different intensities.<br><strong>Results</strong>. In those of CI group, a significant reduction in overall PA volume and intensity was observed. This was evidenced by lower step counts, increased time spent in sedentary behavior and decreased engagement in PA of light and moderate-to-vigorous intensity.<br><strong>Conclusions</strong>. The objective analysis of daily PA patterns using wearable accelerometers holds significant promise for quantifying changes associated with cognitive disorders and may optimize interventions to enhance their activity, thus reducing the impact of cognitive decline.</p>Massimiliano PauGesuina AsoniDaniela VialeValeria Putzu
Copyright (c) 2025 JOURNAL OF GERONTOLOGY AND GERIATRICS
2025-08-042025-08-0473414510.36150/2499-6564-N872Chronic effects of resistance training in women with low bone mineral density associated with medication use: a systematic review
https://www.jgerontology-geriatrics.com/article/view/833
<p><strong>Objective</strong>. To analyze the chronic effects of resistance training in women with low bone mineral density associated with medication use. <br><strong>Methods</strong>. This systematic review followed the recommendations outlined by PRISMA. The databases searched included PubMed, Scopus, Web of Science, SportDiscus, and Scielo. <br><strong>Results</strong>. Six studies met the eligibility criteria and were included in the analysis, covering a total of 233 participants. Three studies incorporated jump exercises in addition to resistance training. Five studies implemented training models with progressive load increases over the intervention weeks, including reassessments for intensity adjustments. <br><strong>Conclusions</strong>. It was concluded that moderate-to-vigorous intensity resistance training programs, when combined with medication use, can be recommended as an accessible, effective, and safe therapeutic strategy for increasing and maintaining bone mineral density in postmenopausal women with osteopenia or osteoporosis.</p>Thayane Sarmento de SouzaRavini de Souza SodréGiullio César Pereira Salustiano Mallen da SilvaAlex Santos MeirelesLenifran de Matos SantosDiego Gama LinharesRodrigo Gomes de Souza Vale
Copyright (c) 2025 JOURNAL OF GERONTOLOGY AND GERIATRICS
2025-08-042025-08-0473465410.36150/2499-6564-N833The longevity of blue zones: myth or reality
https://www.jgerontology-geriatrics.com/article/view/865
<p>The concept of Blue Zones (BZs) refers to regions characterized by an exceptionally high concentration of centenarians, many of whom maintain good health well into advanced age. To date, five such regions have been identified and validated: Sardinia (Italy), Okinawa (Japan), Nicoya (Costa Rica), Ikaria (Greece), and Martinique (a French overseas territory). Despite their widespread recognition, BZs have faced scrutiny over the reliability of demographic data, particularly regarding the accuracy of age reporting. Nevertheless, irrespective of their demographic authenticity, which, as discussed in the review, holds true for the majority of cases, the lifestyle patterns observed in these communities remain highly relevant for the promotion of healthy ageing. Their behavioural and environmental practices provide a robust framework for informing public health strategies aimed at strengthening resilience against non-communicable diseases. Interventions centred on environment and lifestyle and the encouragement of meaningful social engagement have the potential to markedly enhance population health. In fact, minimizing exposure to air pollution and ultra-processed foods, while supporting anti-inflammatory diets, consistent physical activity, and stress management, may significantly reduce the incidence of age-related chronic conditions. As urbanization and modernization continue to reshape daily life, preserving and adapting traditional health-promoting behaviours becomes increasingly important. Policies that support local food production, and enforce regulations to limit environmental degradation may be critical to sustaining the longevity benefits observed in BZs. Ultimately, the exceptional longevity observed in these communities underscores the need for prevention models based on personalized, context-sensitive approaches that integrate ecological and sociocultural factors.</p>Calogero CarusoGiulia AccardiAnna AielloAnna CalabròRosa ZarconeGiuseppina Candore
Copyright (c) 2025 JOURNAL OF GERONTOLOGY AND GERIATRICS
2025-08-042025-08-0473708110.36150/2499-6564-N865Community-based dementia screening initiative in Brunei: pilot study
https://www.jgerontology-geriatrics.com/article/view/838
<p><strong>Objective</strong>. To screen older people and /or those with risk factors for dementia in the community to identify risk factors and possible symptoms of dementia <br><strong>Methods</strong>. A community-based cross-sectional survey was conducted among older people aged 60 years and older or aged 50 years and older with non-communicable diseases or risk factors for developing dementia. Participants were recruited from Senior Citizen Activity Centres and other areas where older people meet in the community, such as marketplaces. Participants completed a structured, self-administered questionnaire regarding self-reported dementia risk factors, cognitive symptoms, concerns regarding symptoms and a brief cognitive assessment tool (Mini-COG). This approach was piloted in the Senior Citizen Activity Centres.<br><strong>Results</strong>. There were 178 participants, median age 67 years with two-thirds being female. Two-thirds had hypertension and over 40% had hypercholesterolaemia. The most commonly reported symptoms were misplacing things (41.6%), visuospatial difficulties (22.7%) and forgetfulness (20.8%). Among those with symptoms, 7.3% reported worsening symptoms, 5.1% had impaired activities of daily living, and 22.5% thought they should get their cognition assessed. For the Mini-COG, 65% recalled all 3 words, while a quarter made at least one error in the clock-drawing test. <br><strong>Conclusions</strong>. Community-based dementia screening using a questionnaire on risk factors, cognitive symptoms and the Mini-COG was feasible and acceptable in Brunei. Despite participants being socially active, there was a surprisingly high prevalence of risk factors for dementia and symptoms of possible cognitive impairment. Further roll-out of the community screening is planned in other locations.</p>Shyh Poh TeoJian Yu LeiMin Banyar HanSiti Munawwarah TarifNorhayati KassimNurul Bazilah AliAsmah Husaini
Copyright (c) 2025 JOURNAL OF GERONTOLOGY AND GERIATRICS
2025-08-042025-08-0473828810.36150/2499-6564-N838